A study found that DFD-29 was more effective than both doxycycline and placebo, with a favorable risk-benefit profile for ...

Patients with moderate to severe papulopustular rosacea have better outcomes with low-dose minocycline than with placebo and ...

Participants were randomized to either daily minocycline hydrochloride (40 mg); doxycycline, the current standard of care; or ...